CLINICAL_TRIALS
trial_result
· 2018-06-26
Clinical Trial Update: Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain [Phase 2]
Summary
Phase 2 trial of pregabalin for G-CSF-induced bone pain in patients with breast cancer or lymphoma was terminated, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2018-06-26